Anticonvulsant use in treating dementia-related agitation

Journal of Pharmacy Practice

Volumn 13, Issue 4, 2000, Pages 308-315

  Gardner, M ^a   Ditmanson, L ^a   Garrett, R W ^a   Luu, T ^a   Meiling, F ^a  

^a Dept of Pharm Practice and Science ^*  (United States)

Author keywords

Agitation; Alzheimer's disease; Anticonvulsant; Antipsychotics; Dementia; GABA

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; FLUOXETINE; GABAPENTIN; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; PHENYTOIN; PLACEBO; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VIGABATRIN;

AGGRESSION; AGITATION; ALZHEIMER DISEASE; BEHAVIOR DISORDER; CLINICAL TRIAL; COGNITION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; META ANALYSIS; NEUROTRANSMISSION; PARKINSONISM; REVIEW; RISK BENEFIT ANALYSIS; SYMPTOM;

EID: 0033803829     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1106/VVAK-4TTG-LXUC-FDLJ     Document Type: Review

References (51)

1. Alzheimer's disease: Etiologies and pathogenesis
2. Treat A. Behavior problems among patients in skilled nursing facilities
3. Mental disorders in the nursing home
4. Neuroleptic drugs in the management of behavioral symptoms of Alzheimer's disease
5. Delusions in newly admitted residents of nursing homes
6. The evolution of psychiatric symptoms in Alzheimer's disease: A natural history study
7. The regional prefrontal syndromes: A theoretical and clinical overview
8. Aggression
9. The use of anticonvulsants in aggression and violence
10. Case report of carbamazepine treatment of organic brain syndrome with psychotic features
11. Carbamazepine in dementia
12. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia
13. Valproate in the treatment of behavioral agitation of dementia
14. Valproate in the treatment of behavioral agitation in elderly patients with dementia
15. The effects of phenytoin on impulsive and premeditated aggression: A controlled study
16. Potential antiepileptic drugs-Gabapentin
17. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs
18. Focus on vigabatrin: A second generation antiepileptic agent for treatment of refractory seizures disorders
19. Use of topiramate, a new anti-epileptic as a mood stabilizer
20. Carbamazepine treatment of agitation in nursing home patients with dementia: A preliminary study
21. Carbamazepine in senile dementia and overactivity: A placebo controlled double-blind trial
22. Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics
23. A preliminary study of carbamazepine in the treatment of assaultive patients with dementia
24. Carbamazepine treatment of agitation in Alzheimer's outpatients refractory to neuroleptics
25. Carbamazepine for aggressive agitation in demented patients during nursing care
26. Carbamazepine treatment of agitation associated with dementia
27. Gabapentin for behavioral agitation in Alzheimer's disease
28. Treatment of dementia-associated agitation with gabapentin
29. Effectiveness of gabapentin for the treatment of behavioral disorders in dementia
30. An open trial of valproate for agitation in geriatric neuropsychiatric disorders
31. Valproic acid treatment of agitation in dementia
32. Treatment of dementia with behavioral disturbances using divalproex or a combination of divalproex and a neuroleptic
33. The effect of sodium valproate on disturbed behavior in dementia
34. The efficacy and tolerability of divalproex sodium in elderly demented patients with behavioral disturbances
35. Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses
36. Sodium valproate in the treatment of behavioral disturbance in dementia
37. Valproic acid for physically aggressive behavior in geriatric patients
38. Valproate treatment of older psychotic patients with organic mental syndromes and behavioral dyscontrol
39. Divalproex sodium in the treatment of aggressive behavior and dysphoria in patients with organic brain syndromes
40. Use of sodium valproate in violent and aggressive behaviors: A critical review
41. An evaluation of antiepileptic drug therapy in nursing facilities
42. Falls in the elderly: Risk factors and prevention
43. Lack of carbamazepine toxicity in frail nursing home patients: A controlled study
44. A review of carbamazepine's hematologic reactions and monitoring recommendations
45. The adverse effect profile and safety of divalproex
46. Cognitive and behavioral effects of antiepileptic drugs
47. Differential cognitive effects of carbamazepine and gabapentin
48. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update
49. Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics
50. Effects of valproate on the pharmacokinetics and pharmacodynamics of lorazepam